FERRARA, PIETRO
 Distribuzione geografica
Continente #
AS - Asia 10.447
NA - Nord America 9.387
EU - Europa 5.387
SA - Sud America 1.274
Continente sconosciuto - Info sul continente non disponibili 530
AF - Africa 239
OC - Oceania 32
Totale 27.296
Nazione #
US - Stati Uniti d'America 8.886
VN - Vietnam 3.195
SG - Singapore 2.884
IT - Italia 2.159
CN - Cina 1.353
HK - Hong Kong 1.228
BR - Brasile 946
RU - Federazione Russa 800
DE - Germania 620
CA - Canada 357
SE - Svezia 336
BD - Bangladesh 335
IE - Irlanda 320
IN - India 304
ID - Indonesia 265
GB - Regno Unito 227
FR - Francia 223
FI - Finlandia 189
KR - Corea 165
AR - Argentina 111
NL - Olanda 110
IQ - Iraq 83
TR - Turchia 71
ZA - Sudafrica 71
ES - Italia 68
MX - Messico 64
PK - Pakistan 61
SA - Arabia Saudita 58
UA - Ucraina 56
IR - Iran 55
AT - Austria 54
JP - Giappone 54
PL - Polonia 47
EC - Ecuador 45
PH - Filippine 44
MY - Malesia 40
CH - Svizzera 39
MA - Marocco 39
TH - Thailandia 37
VE - Venezuela 37
CO - Colombia 36
CL - Cile 35
AU - Australia 30
UZ - Uzbekistan 28
KE - Kenya 25
PY - Paraguay 23
AE - Emirati Arabi Uniti 21
PE - Perù 21
AF - Afghanistan, Repubblica islamica di 19
TN - Tunisia 19
ET - Etiopia 18
JM - Giamaica 18
NP - Nepal 18
JO - Giordania 17
EG - Egitto 16
PT - Portogallo 16
BE - Belgio 14
CZ - Repubblica Ceca 14
DZ - Algeria 14
IL - Israele 14
OM - Oman 14
AL - Albania 13
LT - Lituania 12
TW - Taiwan 12
CR - Costa Rica 11
UY - Uruguay 11
GR - Grecia 10
HN - Honduras 10
KZ - Kazakistan 10
GT - Guatemala 9
NG - Nigeria 9
RO - Romania 9
DO - Repubblica Dominicana 8
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
BH - Bahrain 6
LB - Libano 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
CI - Costa d'Avorio 5
PS - Palestinian Territory 5
QA - Qatar 5
AZ - Azerbaigian 4
BO - Bolivia 4
BZ - Belize 4
DK - Danimarca 4
HU - Ungheria 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
NO - Norvegia 4
YE - Yemen 4
BY - Bielorussia 3
CD - Congo 3
KH - Cambogia 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
Totale 26.710
Città #
Singapore 1.553
Hong Kong 1.190
Ho Chi Minh City 990
Hanoi 911
Ashburn 909
San Jose 889
Milan 634
Ann Arbor 468
Frankfurt am Main 347
Chandler 342
Hefei 320
Dublin 305
New York 298
Dallas 285
Los Angeles 280
Council Bluffs 228
Santa Clara 219
Chicago 218
Toronto 213
Jakarta 195
Fairfield 174
Rome 166
Seoul 156
Beijing 151
Seattle 134
Helsinki 133
Boardman 122
Da Nang 120
The Dalles 120
Princeton 117
Lauterbourg 114
São Paulo 112
Columbus 103
Wilmington 101
Buffalo 98
Houston 91
Haiphong 83
Moscow 79
Orem 74
Woodbridge 71
Quận Bình Thạnh 66
Munich 60
Cambridge 57
Lawrence 56
Nuremberg 54
Atlanta 53
Altamura 52
London 52
Ha Long 50
Thái Nguyên 49
Biên Hòa 48
Lappeenranta 46
Brooklyn 43
Ninh Bình 43
Vũng Tàu 42
Denver 41
San Diego 41
San Francisco 40
Bologna 38
Can Tho 38
Hải Dương 38
Tokyo 38
Montreal 37
Naples 36
Rio de Janeiro 36
Turin 36
Figino 34
Bắc Ninh 32
Warsaw 32
Pune 31
Zurich 31
Phủ Lý 30
Quận Phú Nhuận 30
Salt Lake City 29
Dhaka 28
Riyadh 27
Shanghai 27
Bắc Giang 26
Florence 26
Guangzhou 26
Mexico City 26
Phoenix 26
Quận Một 26
Baghdad 25
Johannesburg 25
Vienna 25
Washington 24
Chennai 23
Kent 23
Lấp Vò 23
New Delhi 23
Amsterdam 22
Tashkent 22
Bangkok 21
Boston 20
Memphis 20
Miami 20
Nairobi 20
Poplar 20
Perugia 19
Totale 15.165
Nome #
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 1.636
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment 634
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 620
Epidemiology of SLE in Italy: an observational study using a primary care database 557
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 509
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 447
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 419
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 407
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 404
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 403
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 368
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 362
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 358
Does age have an impact on acute mountain sickness? A systematic review 333
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 331
Analysis of hospital activity during the COVID-19 pandemic: population-based evidence from highly impacted provinces in northern Italy 307
Association between Daily Pattern of Physical Activity and Depression: A Systematic Review 301
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy 289
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 287
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 286
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 284
Three decades of population health changes in Japan, 1990–2021: a subnational analysis for the Global Burden of Disease Study 2021 278
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 276
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 264
The economic impact of air pollution: a European assessment 255
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 240
Azithromycin use and covid-19: a real-world observational study. 238
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 230
Exploring different modelling approaches to forecast the community acute respiratory infections burden in children: an Italian epidemiological time series study 230
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 226
A silent strain: the unseen burden of acute respiratory infections in children 223
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 220
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 219
A vaginal birth is a cost-reduction strategy for women with a low-lying placenta 213
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 212
The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies 210
Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy 210
Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis, and meta-regression 208
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 208
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 207
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 206
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 202
The use of test-negative case-control studies to determine the effectiveness of influenza vaccination in pregnancy: results from a systematic review and meta-analysis 200
Estimates of cancer mortality attributable to carcinogenic infections in Italy 200
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 198
Knowledge about e-cigarettes and tobacco harm reduction among public health residents in europe 195
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 191
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 191
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 189
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 188
Malaria prevention in the older traveller: A systematic review 186
The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies 186
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 184
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 183
Global injury morbidity and mortality from 1990 to 2017: Results from the Global Burden of Disease Study 2017 177
Redistribution of garbage codes to underlying causes of death: a systematic analysis on Italy and a comparison with most populous Western European countries based on the Global Burden of Disease Study 2019 174
Pre-travel health care attendance among migrant travellers visiting friends and relatives (VFR): A 10-year retrospective analysis 173
Awareness, attitudes, and practices toward meningococcal B vaccine among pediatricians in Italy 172
Alcohol consumption in a sample of Italian healthcare workers: A cross-sectional study 172
COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities 170
Online information about risks and benefits of screening mammography in 10 European countries 167
Estimating global injuries morbidity and mortality: Methods and data used in the Global Burden of Disease 2017 study 163
Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study 162
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 162
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 162
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 161
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 159
Five insights from the Global Burden of Disease Study 2019 159
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 155
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study 153
Renal Resistive Index and 10-Year Risk of Cardiovascular Disease Predicted by Framingham Risk Score and Pooled Cohort Equations: An Observational Study in Hypertensive Individuals Without Cardiovascular Disease 153
Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 152
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 152
Health Technology Assessment and Environmental Impact: A Scoping Review of State of Art and Future Perspective 151
Stime dell'antibiotico-resistenza in Italia e in Europa occidentale nel 2019: un'analisi comparativa basata su MICROBE [Estimates of antibiotic resistance in Italy and Western Europe in 2019: a MICROBE-based comparative analysis] 149
Smoking habits predict adverse effects after mRNA COVID-19 vaccine: Empirical evidence from a pilot study 149
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 146
Stand-by emergency treatment (SBET) of malaria in Spanish travellers: A cohort study 145
Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients 144
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 144
Microsporum nanum cutaneous infection in a traveller returning from Thailand: a diagnostic challenge 144
COVID-19 and healthcare systems: What should we do next? 142
The adherence to guidelines for preventing CVC-related infections: A survey among Italian health-care workers 140
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 140
Health Risk Factors, Prevention, and Inequalities 138
Seafarers' perceptions of job demand: A cross-sectional study 138
Is a second dose of yellow fever vaccine needed? A systematic review of humoral and cell-mediated immunity after revaccination 137
Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019 134
Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019 132
A Systematic Review of Clinical Practice Guidelines for Caries Prevention following the AGREE II Checklist 131
Migrant health burden: Where do we stand? 129
Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN 127
The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 127
The Temporal Correlation Between Positive Testing and Death in Italy: From the First Phase to the Later Evolution of the COVID-19 Pandemic 127
Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 127
The role of neurology in the development of community healthcare within the Italian national health service. The position of the Italian society of neurology (SIN) 126
Assessing the economic burden of disease in migrants: The diabetes case in northern Italy 124
Global, regional, and national burden of diseases and injuries for adults 70 years and older: Systematic analysis for the Global Burden of Disease 2019 Study 123
Analysis of the time evolution of covid-19 lethality during the first epidemic wave in Italy 121
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 121
Totale 23.362
Categoria #
all - tutte 90.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022698 0 54 78 65 73 32 79 55 48 24 85 105
2022/20231.473 115 369 151 133 98 219 36 96 126 29 53 48
2023/20241.742 60 89 82 132 159 354 234 78 153 64 126 211
2024/20256.462 223 471 166 238 351 340 289 163 515 688 566 2.452
2025/202613.661 2.192 1.046 908 1.233 1.270 663 1.707 521 982 1.134 763 1.242
2026/20272.245 1.030 1.215 0 0 0 0 0 0 0 0 0 0
Totale 27.296